A detailed history of Deutsche Bank Ag\ transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 30,314 shares of SAGE stock, worth $173,699. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,314
Previous 26,903 12.68%
Holding current value
$173,699
Previous $292,000 25.34%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.02 - $13.08 $23,945 - $44,615
3,411 Added 12.68%
30,314 $218,000
Q2 2024

Aug 14, 2024

SELL
$10.58 - $17.9 $10.6 Million - $18 Million
-1,003,592 Reduced 97.39%
26,903 $292,000
Q1 2024

May 15, 2024

BUY
$18.62 - $26.95 $51,018 - $73,843
2,740 Added 0.27%
1,030,495 $19.3 Million
Q4 2023

Feb 14, 2024

SELL
$17.1 - $22.26 $9,336 - $12,153
-546 Reduced 0.05%
1,027,755 $22.3 Million
Q3 2023

Nov 09, 2023

SELL
$16.75 - $48.98 $107,870 - $315,431
-6,440 Reduced 0.62%
1,028,301 $21.2 Million
Q2 2023

Aug 14, 2023

BUY
$40.65 - $59.54 $10.5 Million - $15.3 Million
257,328 Added 33.1%
1,034,741 $48.7 Million
Q1 2023

May 15, 2023

BUY
$37.27 - $46.57 $9.3 Million - $11.6 Million
249,494 Added 47.26%
777,413 $32.6 Million
Q4 2022

Feb 13, 2023

SELL
$32.2 - $43.61 $996,557 - $1.35 Million
-30,949 Reduced 5.54%
527,919 $20.1 Million
Q3 2022

Nov 14, 2022

SELL
$32.28 - $43.27 $293,392 - $393,281
-9,089 Reduced 1.6%
558,868 $21.9 Million
Q2 2022

Aug 11, 2022

SELL
$27.52 - $37.99 $313,315 - $432,516
-11,385 Reduced 1.97%
567,957 $18.3 Million
Q1 2022

May 13, 2022

SELL
$30.71 - $45.71 $853,738 - $1.27 Million
-27,800 Reduced 4.58%
579,342 $19.2 Million
Q4 2021

Feb 11, 2022

SELL
$37.06 - $47.11 $924,461 - $1.18 Million
-24,945 Reduced 3.95%
607,142 $25.8 Million
Q3 2021

Nov 04, 2021

BUY
$40.26 - $57.37 $1.01 Million - $1.44 Million
25,177 Added 4.15%
632,087 $28 Million
Q2 2021

Aug 11, 2021

SELL
$54.88 - $79.29 $1.96 Million - $2.82 Million
-35,627 Reduced 5.54%
606,910 $34.5 Million
Q1 2021

May 13, 2021

SELL
$70.65 - $96.76 $5.19 Million - $7.11 Million
-73,528 Reduced 10.27%
642,537 $48.1 Million
Q4 2020

Feb 16, 2021

BUY
$58.41 - $89.06 $25.8 Million - $39.3 Million
441,228 Added 160.54%
716,065 $61.9 Million
Q3 2020

Nov 12, 2020

SELL
$41.13 - $62.45 $1.72 Million - $2.61 Million
-41,858 Reduced 13.22%
274,837 $16.8 Million
Q2 2020

Aug 13, 2020

SELL
$25.95 - $43.15 $3.19 Million - $5.3 Million
-122,863 Reduced 27.95%
316,695 $13.2 Million
Q1 2020

May 14, 2020

BUY
$26.15 - $77.24 $2.07 Million - $6.13 Million
79,314 Added 22.02%
439,558 $12.6 Million
Q4 2019

Feb 14, 2020

BUY
$60.18 - $154.77 $14.2 Million - $36.5 Million
235,590 Added 189.0%
360,244 $26 Million
Q3 2019

Nov 14, 2019

SELL
$140.29 - $189.96 $3.06 Million - $4.15 Million
-21,826 Reduced 14.9%
124,654 $17.5 Million
Q2 2019

Aug 14, 2019

BUY
$157.85 - $183.09 $10.6 Million - $12.3 Million
67,147 Added 84.64%
146,480 $26.8 Million
Q1 2019

May 15, 2019

SELL
$89.33 - $163.65 $5.14 Million - $9.42 Million
-57,587 Reduced 42.06%
79,333 $12.6 Million
Q4 2018

Feb 14, 2019

SELL
$81.94 - $139.71 $2.93 Million - $5 Million
-35,756 Reduced 20.71%
136,920 $13.1 Million
Q3 2018

Dec 21, 2021

BUY
$138.11 - $169.04 $5.03 Million - $6.16 Million
36,452 Added 26.76%
172,676 $24.4 Million
Q3 2018

Nov 14, 2018

SELL
$138.11 - $169.04 $5.67 Million - $6.94 Million
-41,036 Reduced 23.15%
136,224 $19.2 Million
Q2 2018

Apr 21, 2020

BUY
$140.36 - $175.76 $1.66 Million - $2.08 Million
11,851 Added 7.16%
177,260 $27.7 Million
Q2 2018

Aug 14, 2018

SELL
$140.36 - $175.76 $19.4 Million - $24.3 Million
-138,486 Reduced 45.57%
165,409 $25.9 Million
Q1 2018

Oct 18, 2019

BUY
$152.15 - $192.33 $6.97 Million - $8.81 Million
45,832 Added 17.76%
303,895 $48.9 Million
Q1 2018

May 15, 2018

BUY
$152.15 - $192.33 $16.2 Million - $20.4 Million
106,284 Added 70.03%
258,063 $41.6 Million
Q4 2017

Feb 14, 2018

SELL
$60.72 - $167.34 $13.8 Million - $38 Million
-226,840 Reduced 59.91%
151,779 $25 Million
Q3 2017

Nov 14, 2017

BUY
$61.4 - $88.52 $23.2 Million - $33.5 Million
378,619
378,619 $23.6 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.